Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Short Interest Update

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) was the target of a large growth in short interest in June. As of June 30th, there was short interest totalling 139,500 shares, a growth of 65.9% from the June 15th total of 84,100 shares. Based on an average trading volume of 63,500 shares, the short-interest ratio is presently 2.2 days.

Institutional Trading of Ekso Bionics

An institutional investor recently raised its position in Ekso Bionics stock. Strategic Wealth Investment Group LLC lifted its holdings in Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) by 21.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,950 shares of the company’s stock after acquiring an additional 9,285 shares during the quarter. Strategic Wealth Investment Group LLC owned approximately 0.37% of Ekso Bionics worth $130,000 at the end of the most recent reporting period. 6.42% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

EKSO has been the subject of several recent analyst reports. HC Wainwright upped their price objective on shares of Ekso Bionics from $9.25 to $10.00 and gave the stock a “buy” rating in a report on Tuesday, April 30th. Lake Street Capital began coverage on Ekso Bionics in a research report on Monday, June 24th. They issued a “buy” rating and a $2.50 price target on the stock. Finally, StockNews.com started coverage on Ekso Bionics in a research report on Saturday, July 6th. They set a “hold” rating for the company.

Ekso Bionics Price Performance

Shares of NASDAQ EKSO traded up $0.04 during trading hours on Friday, reaching $1.17. The stock had a trading volume of 20,786 shares, compared to its average volume of 132,012. Ekso Bionics has a twelve month low of $0.62 and a twelve month high of $3.13. The business’s fifty day moving average is $1.17 and its two-hundred day moving average is $1.57. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.11 and a current ratio of 2.81.

Ekso Bionics (NASDAQ:EKSO) last posted its earnings results on Monday, April 29th. The company reported ($0.20) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.16) by ($0.04). The business had revenue of $3.76 million during the quarter, compared to the consensus estimate of $4.99 million. Ekso Bionics had a negative net margin of 79.48% and a negative return on equity of 95.36%. During the same period in the previous year, the firm earned ($0.33) EPS. As a group, equities analysts anticipate that Ekso Bionics will post -0.43 earnings per share for the current fiscal year.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.